| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1043 | |
| Phytochemical name or plant extracts | Artemisia herba alba extracts | |
| PMID | 28784534 | |
| Literature evidence | Furthermore, results showed that A. herba alba possess high total antioxidant activity (Total antioxidant activity=423mg gallic acid equivalent/g dry weight), strong potential anticancer capacity against MCF-7 breast cancer and HeLa human cervical cell lines (IC50 of 15 and 70μg/ml, respectively), and moderate antibacterial activity against S. aureus, B. thurigiensis and A. hydrophila. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Ethyl acetate fraction | |
| Source of phytochemicals or plant Extracts | Artemisia herba | |
| Geographical availability | France, Spain | |
| Plant parts | Shoot | |
| Other cancers | Breast cancer, Cervical cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 70 μg/ml against MCF-7 | |
| Potency | NA | |
| Cell line/ mice model | MCF-7, HeLa | |
| Additional information | We show that various phytochemicals of Artemisia herba-alba can be useful against COVID-19 (in silico) and diabetes, malaria, and other diseases (ethnic uses thus far, but clinical trials can be started at an early date). | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:179584-1 | |
| Safety | NA |